Novel therapeutic vaccine formulations

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

09984092

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a novel method and formulation for the induction of immune responses against polypeptide antigens. In particular, the invention provides a method and formulation for induction of cytotoxic T cell responses against a polypeptide antigen of choice. The formulations are characterized by containing chitosan in admixture with the polypeptide antigen, preferably in the form of microparticles that may be cross-linked.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PHARMEXA A/SDANE HESS HOLM

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Beier, Anne Mette Horsholm, DK 1 7
Gautam, Anand Horsholm, DK 6 139
Mouritsen, Soren Horsholm, DK 13 231

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation